g.balogun
Submits third-party assay reports on material purchased directly. Based in Bari.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.56%
n=9
Suppliers covered
6
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043036 | Retatrutide | KP | KP-2607-H5219 | Janoshik | 2026-Q3 | 95.67 | 5.85 | 94.5 | Buyer-sourced | 2 | FAIL |
| AX-2026-043009 | Tirzepatide | KP | KP-2602-X5446 | Janoshik | 2026-Q2 | 98.77 | 6.59 | 99.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041407 | PT-141 (Bremelanotide) | WWB | WWB-2509-A4716 | PeptideMeter | 2026-Q1 | 99.93 | 5.02 | 88.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042130 | Semax | Homopeptide | HOMO-2602-S8315 | Janoshik | 2026-Q1 | 99.56 | 9.36 | 103.4 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043055 | Semax | KP | KP-2509-J5482 | Janoshik | 2026-Q1 | 99.79 | 9.71 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019345 | Retatrutide | TFC | TFC-2503-X7298 | Janoshik | 2025-Q3 | 98.89 | 6.15 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019983 | Semaglutide | ERP | ERP-2508-S6110 | Medutest | 2025-Q3 | 99.90 | 3.28 | 95.8 | Supplier-supplied | 0 | PASS |
| AX-2024-004792 | Retatrutide | Homopeptide | HOMO-2311-R2091 | Janoshik | 2024-Q2 | 97.51 | 3.71 | 95.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005331 | GHRP-6 | SGN | SGN-2401-B9048 | Janoshik | 2024-Q1 | 99.59 | 3.93 | 93.4 | Supplier-supplied | 1 | MARGINAL |